166 related articles for article (PubMed ID: 25720717)
1. Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart.
Wu N; Li WN; Shu WQ; Lv Y; Jia DL
Eur Rev Med Pharmacol Sci; 2015; 19(3):446-54. PubMed ID: 25720717
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia abrogates the cardioprotection of ischemic postconditioning in isolated rat heart: roles of glycogen synthase kinase-3β and the mitochondrial permeability transition pore.
Wu N; Zhang X; Guan Y; Shu W; Jia P; Jia D
Cell Biochem Biophys; 2014 May; 69(1):123-30. PubMed ID: 24213808
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore.
Huhn R; Heinen A; Weber NC; Hollmann MW; Schlack W; Preckel B
Br J Anaesth; 2008 Apr; 100(4):465-71. PubMed ID: 18305078
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of fasudil pretreatment combined with ischemia postconditioning on myocardial ischemia/reperfusion injury in rats.
Li WN; Wu N; Shu WQ; Guan YE; Jia DL
Eur Rev Med Pharmacol Sci; 2014; 18(18):2748-58. PubMed ID: 25317813
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury.
Yao YT; Fang NX; Shi CX; Li LH
Chin Med J (Engl); 2010 May; 123(10):1320-8. PubMed ID: 20529589
[TBL] [Abstract][Full Text] [Related]
7. Morphine Postconditioning Protects Against Reperfusion Injury: the Role of Protein Kinase C-Epsilon, Extracellular Signal-Regulated Kinase 1/2 and Mitochondrial Permeability Transition Pores.
Chen Z; Spahn DR; Zhang X; Liu Y; Chu H; Liu Z
Cell Physiol Biochem; 2016; 39(5):1930-1940. PubMed ID: 27771708
[TBL] [Abstract][Full Text] [Related]
8. Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore.
Dorsch M; Behmenburg F; Raible M; Blase D; Grievink H; Hollmann MW; Heinen A; Huhn R
PLoS One; 2016; 11(3):e0151025. PubMed ID: 26968004
[TBL] [Abstract][Full Text] [Related]
9. Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia.
Torregroza C; Yueksel B; Ruske R; Stroethoff M; Raupach A; Heinen A; Hollmann MW; Huhn R; Feige K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926009
[TBL] [Abstract][Full Text] [Related]
10. Postconditioning with cyclosporine a reduces early renal dysfunction by inhibiting mitochondrial permeability transition.
Lemoine S; Pillot B; Rognant N; Augeul L; Rayberin M; Varennes A; Laville M; Ovize M; Juillard L
Transplantation; 2015 Apr; 99(4):717-23. PubMed ID: 25793558
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of mitochondrial permeability transition pore.
Duan X; Ji B; Yu K; Liu J; Hei F; Long C
ASAIO J; 2011; 57(3):197-202. PubMed ID: 21317634
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitochondrial permeability transition pore opening contributes to the neuroprotective effects of ischemic postconditioning in rats.
Sun J; Luan Q; Dong H; Song W; Xie K; Hou L; Xiong L
Brain Res; 2012 Feb; 1436():101-10. PubMed ID: 22197697
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart.
Wu N; Li W; Shu W; Lv Y; Jia D
Mol Med Rep; 2014 Nov; 10(5):2517-24. PubMed ID: 25231456
[TBL] [Abstract][Full Text] [Related]
14. The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion.
Badalzadeh R; Mohammadi M; Najafi M; Ahmadiasl N; Farajnia S; Ebrahimi H
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):181-9. PubMed ID: 21828282
[TBL] [Abstract][Full Text] [Related]
15. Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse.
Youcef G; Belaidi E; Waeckel L; Fazal L; Clemessy M; Vincent MP; Zadigue G; Richer C; Alhenc-Gelas F; Ovize M; Pizard A
Biochem Pharmacol; 2015 Mar; 94(1):22-9. PubMed ID: 25623731
[TBL] [Abstract][Full Text] [Related]
16. Lycopene restores the effect of ischemic postconditioning on myocardial ischemia‑reperfusion injury in hypercholesterolemic rats.
Duan L; Liang C; Li X; Huang Z; Liu S; Wu N; Jia D
Int J Mol Med; 2019 Jun; 43(6):2451-2461. PubMed ID: 31017253
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts.
Nazari A; Sadr SS; Faghihi M; Azizi Y; Hosseini MJ; Mobarra N; Tavakoli A; Imani A
Eur J Pharmacol; 2015 Aug; 760():96-102. PubMed ID: 25895639
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo.
Huhn R; Heinen A; Hollmann MW; Schlack W; Preckel B; Weber NC
Nutr Metab Cardiovasc Dis; 2010 Dec; 20(10):706-12. PubMed ID: 19819119
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological postconditioning with sappanone A ameliorates myocardial ischemia reperfusion injury and mitochondrial dysfunction via AMPK-mediated mitochondrial quality control.
Shi X; Li Y; Wang Y; Ding T; Zhang X; Wu N
Toxicol Appl Pharmacol; 2021 Sep; 427():115668. PubMed ID: 34358556
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A Plus Ischemic Postconditioning Improves Neurological Function in Rats After Cardiac Resuscitation.
Zhou X; Qu Y; Gan G; Zhu S; Huang Y; Liu Y; Zhu J; Xie B; Tan Z
Neurocrit Care; 2020 Jun; 32(3):812-821. PubMed ID: 31576483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
